Accellta

Industrial-Scale Stem Cell Culturing for Research and Medicine

Startup

Accellta is a Haifa-based startup in the Health Tech & Life Sciences sector, established in 2012. Industrial-Scale Stem Cell Culturing for Research and Medicine. The company has raised a total of $500K across 3 funding rounds, currently at the Mature stage. Key investors include AMIT-Technion ( The Alfred Mann Institute), Horizons Ventures. The company has 11-50 employees. Core technologies: Biologicals, Cells.

With $500K in total funding, Accellta is a Mature-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent.

$500K
Raised
3
Rounds
2
Investors
4
Team
2012
Founded
1
Patents
Sector & Technology
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & DevelopmentBiologicalsCells
At a Glance
Investors
In the News

7 articles covered by sources including www.globes.co.il, knect365.com, www.prnewswire.com, globenewswire.com, www.businesswire.com.

www.globes.co.il · Mar 13, 2018
Hitachi Chemical licenses stem cell tech from Israel's Accellta
Read article ↗
Frequently Asked Questions
What does Accellta do?

Accellta specializes in large-scale production of embryonic and induced pluripotent stem cells, progenitors, and differentiated cells. These products are used in cell banking, drug discovery, regenerative medicine, and scientific research. The company uses 3D carrier-free suspension systems under feeder-free, adherent-free, and xeno-free conditions, optimizing production efficiency and reducing costs while maintaining consistent quality. Accellta's manufacturing facility adheres to Good Manufacturing Practice (GMP) guidelines, supporting industrial-scale cell banking and clinical batch production. The company’s patent portfolio covers media formulations and pluripotent stem cell culturing techniques, reflecting its focus on advancing cell culture technologies.

How much funding has Accellta raised?

Accellta has raised $500K in total funding across 3 rounds. The company is currently at the Mature stage. Key investors include AMIT-Technion ( The Alfred Mann Institute), Horizons Ventures.

What sector is Accellta in?

Accellta operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Drugs Discovery & Development, with core technologies in Biologicals, Cells. Target customers: Agriculture & Food, Processed Foods, Beverages, Healthcare & Life Sciences, Life Sciences, Pharmaceuticals, Biotechnology, Healthcare, Providers, Laboratories, Industrial Manufacturing, Manufacturing Facilities.

Where is Accellta located?

Accellta is based in Haifa, Israel, North District.

View Full Profile Classic View Website ↗